Article
Nucleic Acid Point-of-Care Testing to Improve Diagnostic Preparedness
5 Jan 2022
Abstract excerpt
Testing programs for severe acute respiratory syndrome coronavirus 2 have relied on high-throughput polymerase chain reaction laboratory tests and rapid antigen assays to meet diagnostic needs. Both technologies are essential; however, issues of cost, accessibility, manufacturing delays, and performance have limited their use in low-resource settings and contributed to the global inequity in coronavirus disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
